LBA
PMD

Lowell Blake & Associates’s Psychemedics Corporation PMD Stock Holding History

Lowell Blake & Associates’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-12,212
Closed -$112K – 59
2019
Q4 		$112K Buy
+12,212
New +$113K 0.12% 57

Other funds holding PMD

KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Lowell Blake & Associates's PMD Position: Q1 2020 in Review

Lowell Blake & Associates sold out of Psychemedics Corporation (PMD) in Q1 2020, closing a stake of 12,212 shares — an estimated $112K sold.

Lowell Blake & Associates first reported a position in PMD in Q4 2019 and held it in 1 quarter. The position peaked at $112K in Q4 2019. 37 funds tracked by Wall St. Rank hold PMD as of Q1 2020.

  • Lowell Blake & Associates reported no remaining Psychemedics Corporation position as of Q1 2020 after selling out during the quarter.
  • Lowell Blake & Associates sold 12,212 Psychemedics Corporation shares in Q1 2020, an estimated $112K.
  • Lowell Blake & Associates first reported a position in Psychemedics Corporation in Q4 2019 and held it in 1 quarter.
  • Lowell Blake & Associates's Psychemedics Corporation position peaked at $112K in Q4 2019.
  • 37 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q1 2020.

Based on Lowell Blake & Associates's 13F filing for Q1 2020, filed 1 Jul 2020.